|
US3845770A
(en)
|
1972-06-05 |
1974-11-05 |
Alza Corp |
Osmatic dispensing device for releasing beneficial agent
|
|
US4326525A
(en)
|
1980-10-14 |
1982-04-27 |
Alza Corporation |
Osmotic device that improves delivery properties of agent in situ
|
|
US5877193A
(en)
|
1996-07-19 |
1999-03-02 |
Hoffmann-La Roche Inc. |
Use of N-(4-aryl-thiazol-2-yl)-sulfonamides
|
|
DE69809222T2
(de)
|
1997-05-07 |
2003-08-14 |
Galen (Chemicals) Ltd., Dublin |
Vorrichtungen zur intravaginalen verabreichung von testosteron und testosteron-vorläuferverbindungen
|
|
AU2201500A
(en)
|
1999-01-13 |
2000-08-01 |
Warner-Lambert Company |
Benzenesulfonamide derivatives and their use as mek inhibitors
|
|
DK1202724T3
(da)
|
1999-07-16 |
2004-01-26 |
Warner Lambert Co |
Fremgangsmåde til behandling af kronisk smerte under anvendelse af mek-inhibitorer
|
|
GB9928568D0
(en)
|
1999-12-03 |
2000-02-02 |
Zeneca Ltd |
Chemical compounds
|
|
FR2836917B1
(fr)
|
2002-03-11 |
2006-02-24 |
Lipha |
Derives nitroso de la diphenylamine, compositions pharmaceutiques les contenant en tant que medicaments utilisables dans le traitement des pathologies caracterisees par une situation de stress oxydatif
|
|
AU2003243921B2
(en)
|
2002-06-27 |
2009-05-07 |
Novo Nordisk A/S |
Aryl carbonyl derivatives as therapeutic agents
|
|
WO2004092123A2
(en)
|
2003-04-10 |
2004-10-28 |
Microbia, Inc. |
Inhibitors of fungal invasion
|
|
WO2005000309A2
(en)
|
2003-06-27 |
2005-01-06 |
Ionix Pharmaceuticals Limited |
Chemical compounds
|
|
JP2009513523A
(ja)
|
2003-07-08 |
2009-04-02 |
ノバルティス アクチエンゲゼルシャフト |
ベンゼンスルホニルアミノ化合物およびそれらを含む医薬組成物
|
|
TW200524888A
(en)
|
2003-08-08 |
2005-08-01 |
Vertex Pharma |
Compositions useful as inhibitors of voltage-gated ion channels
|
|
ZA200601942B
(en)
*
|
2003-08-08 |
2007-05-30 |
Vertex Pharma |
Heteroarylaminosulfonylphenyl derivatives for use as sodium or calcium channel blockers in the treatment of pain
|
|
HU227684B1
(en)
|
2003-08-29 |
2011-11-28 |
Sanofi Aventis |
Adamantane and azabicyclo-octane and nonane derivatives and their use as dpp-iv inhibitors
|
|
JP2008524244A
(ja)
|
2004-12-17 |
2008-07-10 |
タケダ サン ディエゴ インコーポレイテッド |
水酸化ステロイド脱水素酵素阻害剤
|
|
GB0510139D0
(en)
|
2005-05-18 |
2005-06-22 |
Addex Pharmaceuticals Sa |
Novel compounds B1
|
|
RU2008113210A
(ru)
|
2005-10-06 |
2009-10-10 |
Санофи-Авентис (Fr) |
4-окси-n-[1, 3, 4]-тиадиазол-2-илбензолсульфонамиды, способы их получения и их применение в качестве фармацевтических средств
|
|
NZ593074A
(en)
|
2005-12-21 |
2012-04-27 |
Vertex Pharma |
sulfonamide-pyrrolidone derivatives as Modulators of Ion Channels
|
|
KR101117931B1
(ko)
|
2006-08-15 |
2012-04-12 |
에프. 호프만-라 로슈 아게 |
페닐, 피리딘 및 퀴놀린 유도체
|
|
ES2383370T3
(es)
|
2006-10-19 |
2012-06-20 |
Signal Pharmaceuticals Llc |
Compuestos de heteroarilo, sus composiciones y uso de los mismos como inhibidores de proteína quinasa
|
|
CA2694748A1
(en)
|
2007-07-13 |
2009-01-22 |
Icagen, Inc. |
Sodium channel inhibitors
|
|
EP2173743A2
(en)
*
|
2007-07-13 |
2010-04-14 |
Icagen, Inc. |
Sodium channel inhibitors
|
|
WO2009013171A2
(en)
|
2007-07-24 |
2009-01-29 |
F. Hoffmann-La Roche Ag |
Heterocyclic antiviral compounds
|
|
JP5555169B2
(ja)
*
|
2007-10-11 |
2014-07-23 |
バーテックス ファーマシューティカルズ インコーポレイテッド |
電位開口型ナトリウムチャネルの阻害剤として有用なヘテロアリールアミド
|
|
CA2727340A1
(en)
|
2008-06-25 |
2009-12-30 |
Daiichi Sankyo Company, Limited |
Carboxylic acid compound
|
|
CN102099356A
(zh)
|
2008-07-01 |
2011-06-15 |
沃泰克斯药物股份有限公司 |
用作离子通道调节剂的杂环衍生物
|
|
GB0815947D0
(en)
*
|
2008-09-02 |
2008-10-08 |
Univ Dundee |
Compounds
|
|
WO2010029300A1
(en)
|
2008-09-12 |
2010-03-18 |
Biolipox Ab |
Bis aromatic compounds for use in the treatment of inflammation
|
|
HUE025013T2
(hu)
|
2009-01-12 |
2016-04-28 |
Pfizer Ltd |
Szulfonamid-származékok
|
|
CA2804593C
(en)
|
2010-07-09 |
2015-11-24 |
Pfizer Limited |
Biphenyloxybenzensulphonamide derivatives useful as sodium channel inhibitors
|
|
JP5749341B2
(ja)
|
2010-08-20 |
2015-07-15 |
ハチソン メディファーマ リミテッド |
ピロロピリミジン化合物およびその使用
|
|
AU2012296529A1
(en)
|
2011-08-17 |
2014-02-20 |
Amgen Inc. |
Heteroaryl sodium channel inhibitors
|
|
MX2014005068A
(es)
|
2011-10-28 |
2014-07-30 |
Merck Sharp & Dohme |
Compuestos de benzoxazolinona con actividad selectiva en canales de sodio activados por voltaje.
|
|
ES2586213T3
(es)
*
|
2011-10-31 |
2016-10-13 |
Xenon Pharmaceuticals Inc. |
Compuestos de bencenosulfonamida y su uso como agentes terapéuticos
|
|
JP6014155B2
(ja)
|
2011-10-31 |
2016-10-25 |
ゼノン・ファーマシューティカルズ・インコーポレイテッドＸｅｎｏｎ Ｐｈａｒｍａｃｅｕｔｉｃａｌｓ Ｉｎｃ． |
ビアリールエーテルスルホンアミドおよび治療剤としてのそれらの使用
|
|
US8889741B2
(en)
|
2012-02-09 |
2014-11-18 |
Daiichi Sankyo Company, Limited |
Cycloalkane derivatives
|
|
US9346798B2
(en)
|
2012-02-13 |
2016-05-24 |
Amgen Inc. |
Dihydrobenzoxazine and tetrahydroquinoxaline sodium channel inhibitors
|
|
BR112014029161A2
(pt)
|
2012-05-22 |
2017-06-27 |
Genentech Inc |
benzamidas n-substituídas e seu uso no tratamento de dor
|
|
WO2014061970A1
(en)
|
2012-10-15 |
2014-04-24 |
Daewoong Pharmaceutical Co., Ltd. |
Sodium channel blockers, preparation method thereof and use thereof
|
|
US9624208B2
(en)
|
2012-10-26 |
2017-04-18 |
Merck Sharp & Dohme Corp. |
Benzoxazolinone compounds with selective activity in voltage-gated sodium channels
|
|
US9388179B2
(en)
|
2012-10-26 |
2016-07-12 |
Merck Sharp & Dohme Corp. |
N-substituted indazole sulfonamide compounds with selective activity in voltage-gated sodium channels
|
|
TW201443025A
(zh)
|
2013-04-19 |
2014-11-16 |
Pfizer Ltd |
化學化合物
|
|
TW201512171A
(zh)
|
2013-04-19 |
2015-04-01 |
Pfizer Ltd |
化學化合物
|
|
US9776995B2
(en)
|
2013-06-12 |
2017-10-03 |
Amgen Inc. |
Bicyclic sulfonamide compounds as sodium channel inhibitors
|
|
GB201310542D0
(en)
|
2013-06-13 |
2013-07-31 |
Antabio Sas |
Compounds
|
|
WO2015035278A1
(en)
|
2013-09-09 |
2015-03-12 |
Bristol-Myers Squibb Company |
RORγ MODULATORS
|
|
CN105611923B
(zh)
|
2013-09-10 |
2019-08-23 |
卓莫赛尔公司 |
用于治疗疼痛和糖尿病的钠通道调节剂
|
|
WO2015077905A1
(en)
|
2013-11-29 |
2015-06-04 |
Merck Sharp & Dohme Corp. |
Bicycloamine-substituted-n-benzenesulfonamide compounds with selective activity in voltage-gated sodium channels
|
|
AU2014370407B2
(en)
|
2013-12-23 |
2018-03-29 |
Purdue Pharma L.P. |
Indazoles and use thereof
|
|
EP3110794A1
(en)
*
|
2014-02-27 |
2017-01-04 |
Merck Patent GmbH |
Heterocyclic compounds as nav channel inhibitors and uses thereof
|
|
RS60906B1
(sr)
*
|
2014-10-06 |
2020-11-30 |
Vertex Pharma |
Modulatori regulatora transmembranske provodljivosti za cističnu fibrozu
|
|
KR102412146B1
(ko)
*
|
2015-02-11 |
2022-06-22 |
주식회사 아이엔테라퓨틱스 |
소디움 채널 차단제
|
|
CN106795149B
(zh)
|
2015-05-05 |
2019-09-24 |
上海海雁医药科技有限公司 |
双环取代的苯磺酰胺衍生物、其制法与医药上的用途
|
|
WO2017106409A1
(en)
|
2015-12-18 |
2017-06-22 |
Merck Sharp & Dohme Corp. |
Diamino-alkylamino-linked arylsulfonamide compounds with selective activity in voltage-gated sodium channels
|
|
KR102366077B1
(ko)
|
2016-05-20 |
2022-02-21 |
제논 파마슈티칼스 인크. |
벤젠술폰아미드 화합물 및 치료제로서의 그의 용도
|
|
WO2018017896A1
(en)
*
|
2016-07-20 |
2018-01-25 |
Amgen Inc. |
Pyridine sulfonamides
|
|
TW201811766A
(zh)
*
|
2016-08-29 |
2018-04-01 |
瑞士商諾華公司 |
N-(吡啶-2-基)吡啶-磺醯胺衍生物及其用於疾病治療之用途
|
|
EP3541373B1
(en)
|
2016-11-17 |
2023-11-01 |
Merck Sharp & Dohme LLC |
Diamino-alkylamino-linked arylsulfonamide compounds with selective activity in voltage-gated sodium channels
|
|
KR20190086772A
(ko)
|
2016-12-09 |
2019-07-23 |
제논 파마슈티칼스 인크. |
벤젠술폰아미드 화합물 및 치료제로서의 그의 용도
|
|
MX2021000987A
(es)
*
|
2018-07-27 |
2021-06-15 |
Xenon Pharmaceuticals Inc |
Metodo para tratar la epilepsia.
|